Overview
Oxford Instruments announced preliminary full-year results showing revenue of
Financial highlights
The group's preliminary full-year revenue was reported at
Adjusted operating profit for the year came in at
The adjusted operating margin was 17.40% for the period. During the year the company completed the sale of its NanoScience division and returned capital to shareholders through
Orders and segment performance
Orders in the Advanced Technologies division grew by 28% over the year, a rise the company said provides visibility into future revenues and supports growth. Management reported the order book now covers planned revenue for fiscal year 2027, with purchase orders extending into fiscal year 2028.
The Imaging & Analysis segment delivered margin improvement and profit growth. The company attributed this to the restructuring of its Belfast cameras and microscopy operations and to improved operational execution.
Management noted the divestment of NanoScience contributed to an improvement in the group's operating margin and allowed the firm to concentrate on higher value growth opportunities.
Outlook and investment plans
Oxford Instruments reiterated confidence in achieving a medium-term organic revenue compound annual growth rate target of 5% to 8%. The company also said it plans to raise research and development investment in fiscal year 2027.
Note on disclosure
No additional disclosures were provided in the company statement included in these results.